Susan G. Komen is the only organization that addresses breast cancer on multiple
fronts such as research, community health, global outreach and public policy initiatives
to make the biggest impact against this disease.
More than 40 years ago, a sisterly promise ignited a spark that would fuel a global
crusade against breast cancer. Today that promise continues to prevail as the driving
force behind Komen?s unwavering quest for a future free from the grip of this deadly
disease.
In the pursuit of our goals, we?ve helped fuel research, unlocking the biology of breast
cancer and discovering insights that propel us toward more effective risk reduction
strategies, earlier detection methods and innovative treatments. This has helped reduce
the breast cancer mortality rate by 44% since 1989.
To date, we?ve invested nearly $3.6 billion in groundbreaking research, community
health outreach, advocacy and programs in more than 60 countries. Over the past 30
years, more than 30 new FDA-approved breast cancer-fighting drugs were made
possible in part due to Komen research funding.
We stand firm in our promise to never give up on our vision of creating a world without
breast cancer. Learn more by visiting komen.org or calling 1-877 GO KOMEN.